Clinical trial
Study of the Relationship Between the Presence of Anti-AChR Antibodies in the Cerebrospinal Fluid and the Presence of Neurocognitive Disorder in Myasthenic and Alzheimers's Patients.
NCT06523296 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Relationship Between the Presence of Anti-AChR Antibodies in the Cerebrospinal Fluid and the Presence of Neurocognitive Disorder in Myasthenic and Alzheimers's Patients.
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 18, 2026
- Completion date
- September 18, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, myasthenia